Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Clinical trial NCT00445406 · COMPLETED
Trial details
- NCT number
- NCT00445406
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-09-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.